Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Krug

Showing results (11-20 of 198) with videos related to

Pageof 20
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2023
[Stereotactic radiotherapy plus nivolumab in the treatment of non-small-cell lung cancer]David Krug, Jürgen Dunst
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 2015
[Determination of prognosis using gene expression analyses: Consequences for the indication for radiotherapy?]René Baumann, David Krug
The Lancet. Oncology|March 7, 2018
Neoadjuvant chemotherapy for early breast cancerDavid Krug, Sibylle Loibl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 14, 2019
[Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides]Alexander Fabian, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 19, 2022
[Enzalutamide vs active surveillance in patients with low-risk prostate cancer]Jürgen Dunst, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 24, 2025
[Comparison of quality of life between single-modality adjuvant endocrine therapy versus radiotherapy for patients with low-risk breast cancer]Sophia Drabke, David Krug
Breast Care (Basel, Switzerland)|November 25, 2015
Radiotherapy of Ductal Carcinoma In SituDavid Krug, Rainer Souchon
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 15, 2017
[Radiochemotherapy improves failure-free survival in stage III endometrial cancer : Final results of the PORTEC-3 trial]David Krug, Nathalie Arians
The Lancet. Oncology|June 14, 2025
Partial-breast irradiation: has the dust finally settled?David Krug, Jürgen Dunst
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 18, 2020
[Adjuvant radiotherapy in low-risk breast cancer: long-term results of the ABCSG-8A trial]David Krug, Marciana-Nona Duma
Pageof 20

Showing results (11-20 of 198) with videos related to

Sort By:
Pageof 20
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2023
[Stereotactic radiotherapy plus nivolumab in the treatment of non-small-cell lung cancer]David Krug, Jürgen Dunst
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 2015
[Determination of prognosis using gene expression analyses: Consequences for the indication for radiotherapy?]René Baumann, David Krug
The Lancet. Oncology|March 7, 2018
Neoadjuvant chemotherapy for early breast cancerDavid Krug, Sibylle Loibl
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 14, 2019
[Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides]Alexander Fabian, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 19, 2022
[Enzalutamide vs active surveillance in patients with low-risk prostate cancer]Jürgen Dunst, David Krug
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 24, 2025
[Comparison of quality of life between single-modality adjuvant endocrine therapy versus radiotherapy for patients with low-risk breast cancer]Sophia Drabke, David Krug
Breast Care (Basel, Switzerland)|November 25, 2015
Radiotherapy of Ductal Carcinoma In SituDavid Krug, Rainer Souchon
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 15, 2017
[Radiochemotherapy improves failure-free survival in stage III endometrial cancer : Final results of the PORTEC-3 trial]David Krug, Nathalie Arians
The Lancet. Oncology|June 14, 2025
Partial-breast irradiation: has the dust finally settled?David Krug, Jürgen Dunst
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 18, 2020
[Adjuvant radiotherapy in low-risk breast cancer: long-term results of the ABCSG-8A trial]David Krug, Marciana-Nona Duma
Pageof 20